HIV-1 protease does not play a critical role in the early stages of HIV-1 infection

Antiviral Research

Volumn 36, Issue 2, 1997, Pages 107-113

  Uchida, Hiroyuki ^a   Maeda, Yosuke ^a   Mitsuya, Hiroaki ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

Human immunodeficiency virus type 1; Protease inhibitors; Proviral DNA

Indexed keywords

CHLORAMPHENICOL ACETYLTRANSFERASE; KYNOSTATIN 272; PROTEIN PRECURSOR; PROTEINASE; PROTEINASE INHIBITOR; RITONAVIR; RNA DIRECTED DNA POLYMERASE; SAQUINAVIR;

ARTICLE; CONTROLLED STUDY; DNA SYNTHESIS; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; VIRUS REPLICATION;

CHLORAMPHENICOL O-ACETYLTRANSFERASE; HELA CELLS; HIV INFECTIONS; HIV PROTEASE; HIV PROTEASE INHIBITORS; HIV-1; HUMANS; OLIGOPEPTIDES; RITONAVIR; SAQUINAVIR;

FELIS CATUS; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 0030815316     PISSN: 01663542     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0166-3542(97)00047-8     Document Type: Article

References (23)

1. Baboonian C., Dalgleish A., Bountiff L., Gross J., Oroszlan S., Rickett G., Smith-Burchnell C., Troke P., Merson J. HIV-1 proteinase is required for synthesis of proviral DNA. Biochem. Biophys. Res. Commun. 179:1991;17-24.
2. Ciminale V., Felber B.K., Campbell M., Pavlakis G.N. A bioassay for HIV-1 based on Env-CD4 interaction. AIDS Res. Hum. Retroviruses. 6:1990;1281-1287.
3. Clouse K.A., Powell D., Washington I., Poli G., Strebel K., Farrar W., Barstad P., Kovacs J., Fauci A.S., Folks T.M. Monokine regulation of human immunodeficiency virus-1 expression in a chronically infected human T cell clone. J. Immunol. 142:1989;431-438.
4. 2 symmetric inhibitor complexed to HIV-1 protease. Science. 249:1990;527-533.
5. Hoffmann K., Tynes R.E. Stable chinese hamster ovary reporter gene cells used i n drug safety and drug development - the nonradioactive CAT ELISA. Biochemica. 1:1995;30-32.
6. Jacobsen H., Ahlborn L.L., Gugel R., Mous J. Progression of early steps of human immunodeficiency virus type l replication in the presence of an inhibitor of viral protease. J. Virol. 66:1992;5087-5091.
7. Kageyama S., Mimoto T., Murakawa Y., Nomizu M., Ford H. Jr., Shirasaka T., Gulnick S., Erickson J., Takada K., Hayashi H., Broder S., Kiso Y., Mitsuya H. In vitro anti-HIV activities of transition state mimetic HIV protease inhibitors containing allphenylnorstatine. Antimicrob. Agents Chemother. 37:1993;810-817.
8. Kageyama S., Hoekzema D.T., Murakawa Y., Kojima E., Shirasaka T., Kempf D.J., Norbeck D.W., Erickson J., Mitsuya H. A C2 symmetry-based HIV protease inhibitor, A77003, irreversibly inhibits infectivity of HIV-1 in vitro. AIDS Res. Hum. Retroviruses. 10:1994;735-743.
9. Kaplan A.H., Manchester M., Smith T., Yang Y.L., Swanstrom R. Conditional human immunodeficiency virus type l protease mutants show no role for the viral protease early in virus replication. J. Virol. 70:1996;5840-5844.
10. Katoh I., Yasunaga T., Ikawa Y., Yoshinaka Y. Inhibition of retroviral protease activity by an aspartyl proteinase inhibitor. Nature. 329:1987;654-656.
11. Kempf D.J., Marsh K.C., Denissen J.F., McDonald E., Vasavanonda S., Flentge C.R., Green B.E., Fino L., Park C.H., Kong X.P., Wideburg N.E., Saldivar A., Ruiz L., Kati W.M., Sham H.L., Robins T., Stewart K.D., Hsu A., Plattner J.J., Leonard J.M., Norbeck D.W. ABT-538 is a potent inhibitor of human immunodeficiency virus protease and has high oral bioavailability in humans. Proc. Natl. Acad. Sci. USA. 92:1995;2484-2488.
12. Kimpton J., Emerman M. Detection of replication-competent and pseudotype human immunodeficiency virus with a sensitive cell line on the basis of activation of an integrated beta-galactosidase gene. J. Virol. 66:1992;2232-2239.
13. Kramer R.A., Schaber M.D., Skalka A.M., Ganguly K., Wong S.F., Reddy E.P. HTLV-III gag protein is processed in yeast cells by the virus pol-protease. Science. 23(1):1986;1580-1584.
14. Leland, D.S., French, M.V., 1988. Virus isolation and identification. Laboratory diagnosis of infectious diseases: Principles and practice. In: Lennette, E., Halonen, P., Murphy, F. (Eds.), Springer-Verlag, New York.
15. Mimoto T., Imai J., Kisanuki S., Enomoto H., Hattori N., Akaji K., Kiso Y. Kynostatin (KNI)-227 and -272, highly potent anti-HIV agents: Conformationally constrained tripeptide inhibitors of HIV protease containing allo phenylnorstatine. Chem. Pharm. Bull. 39:1992;2465-2467.
16. Nagy K., Young M., Baboonian C., Merson J., Whittle P., Oroszlan S. Antiviral activity of human immunodeficiency virus type 1 protease inhibitors in a single cycle of infection: Evidence for a role of protease in the early phase. J. Virol. 68:1994;757-765.
17. Overton H.A., McMillan D.J., Gridley S.J., Brenner J., Redshaw S., Mills J.S. Effect of two novel inhibitors of the human immunodeficiency virus protease on the maturation of the HIV gag and gag-pol polyproteins. Virology. 179:1990;508-511.
18. Roberts M.M., Copeland T.D., Oroszlan S. In situ processing of a retroviral nucleocapsid protein by the viral proteinase. Protein Eng. 4:1991;695-700.
19. Roberts M.M., Oroszlan S. The preparation and biochemical characterization of intact capsids of equine infectious anemia virus. Biochem. Biophys. Res. Commun. 160:1989;486-494.
20. Roberts N.A., Martin J.A., Kinchington D., Broadhurst A.V., Craig C., Duncan I.B., Galpin S.A., Handa B.K., Kay J., Kröhn A., Lambert R.W., Merrett J.H., Mills J.S., Parkes K.E.B., Redshaw S., Ritchie A.J., Taylor D.L., Thomas G.J., Machin P.J. Rational design of peptide-based HIV proteinase inhibitors. Science. 248:1990;358-361.
21. Venaud S., Yahi N., Fehrentz J.L., Guettari N., Nisato D., Hirsch I., Chermann J. Inhibition of HIV by an anti-HIV protease synthetic peptide blocks an early step of viral replication. Res. Virol. 143:1992;311-319.
22. von der Helm K. Cleavage of Rous sarcoma viral polypeptide precursor into internal structural proteins in vitro involves viral protein p15. Proc. Natl. Acad. Sci. USA. 74:1977;911-915.
23. Yoshinaka Y., Luftig R.B. Properties of a P70 proteolytic factor of murine leukemia viruses. Cell. 12:1977;709-915.